Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05952206 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05952206 · ClinicalTrials.gov record · last posted 2026-05-15

Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy

Study acronym: ANGIODAPT
StatusActive, Not Recruiting
PhasePhase 3
Started2023-10-13
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
Factorial 2x2, all-comer, multicentre, randomized controlled trial (ratio 1:1:1:1). First, the study will compare (first randomization) the non-inferiority in target lesion failure of angiolite stent versus Xience stent family. Immediately after the first randomization, the study compares (second randomization) the superiority in bleeding Bleeding Academic Research Consortium (BARC) 2, 3, or 5 of abbreviated DAPT versus standard of care. Both primary endpoints will be evaluated at 12 months of follow-up. The study will be open-label for the stent type and the antiplatelet regimen.

Amendment record 2 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 2 times since 2023-07-11; most recent amendment 2026-05-12. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2026-05-12
Status change Recruiting→Active, Not Recruitingv2
2025-05-13
Status change Not Yet Recruiting→Recruitingv1
Trial Details
NCT Number NCT05952206
Lead Sponsor iVascular S.L.U.
Conditions Coronary Artery Disease
Enrollment 2,312 participants
Start Date 2023-10-13
Primary Completion 2027-01-13 (estimated)
Study Completion 2030-01-13 (estimated)
Updated on ClinicalTrials.gov 2026-05-15